Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
US FDA Classification
|
Strong Performer, Under Radar
884.2500
-0.05
(
-0.01
%)
NSE
Sep 19, 2025
15:31 PM
42.13% Fall from 52W High
Volume:
392.8K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
19 Mar 2025
US FDA Classification
884.25
-0.01%
NATCO PHARMA
Hold:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 887 | Target met
Target
Geojit BNP Paribas
Geojit BNP Paribas decreased Hold price target of Natco Pharma Ltd. to 940.0 on 17 Sep, 2025.
More from Natco Pharma Ltd.
Recommended
Five Interesting Stocks Today - September 19, 2025
The Baseline |
19 Sep 2025, 04:31PM
Market closes lower, JSW Energy arm to acquire Tidong Power
Trendlyne Marketwatch |
19 Sep 2025, 03:58PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020